Shortening MDR-TB treatment: is treating more patients with fewer drugs better?

被引：4
|
作者：
Akkerman, O. W. [1 ,2 ]
Tiberi, S. [3 ,4 ]
Alffenaar, J-W. [5 ,6 ,7 ]
机构：
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis & TB, Hanzepl 1, NL-9713 GZ Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, TB Ctr Beatrixoord, Haren, Netherlands
[3] Barts Hlth NHS Trust, Dept Infect, London, England
[4] Queen Mary Univ London, Blizard Inst, London, England
[5] Univ Sydney, Fac Med & Hlth, Sch Pharm, Sydney, NSW, Australia
[6] Westmead Hosp, Sydney, NSW, Australia
[7] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia
来源：
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE | 2021年 / 25卷 / 06期
关键词：
MULTIDRUG-RESISTANT TUBERCULOSIS; BEDAQUILINE;
D O I：
10.5588/ijtld.21.0146
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：419 / 420
页数：2
相关论文
共 50 条
  • [31] STREAM: a pragmatic and explanatory trial for MDR-TB treatment
    Abubakar, Ibrahim
    Meredith, Sarah
    Nunn, Andrew J.
    Phillips, Patrick P. J.
    Rusen, I. D.
    [J]. LANCET INFECTIOUS DISEASES, 2019, 19 (06): : 575 - 576
  • [32] Retrospective audit of patients treated for MDR-TB in re-treatment category
    Saeed, Waseem
    Naseem, Arshad
    Ahmed, Jamal
    [J]. JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2013, 63 (01) : S70 - S74
  • [33] 'ZS-MDR-TB' versus 'ZR-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility
    Zhang, Ying
    Chang, Kwok Chiu
    Leung, Chi-Chiu
    Yew, Wing Wai
    Gicquel, Brigitte
    Fallows, Dorothy
    Kaplan, Gilla
    Chaisson, Richard E.
    Zhang, Wenhong
    [J]. EMERGING MICROBES & INFECTIONS, 2012, 1
  • [34] Outcome of standardized treatment for patients with MDR-TB from Tamil Nadu, India
    Joseph, Pauline
    Desai, Vijaya Bhaskara Rao
    Mohan, Nalini Sunder
    Fredrick, Jemima Sheila
    Ramachandran, Rajeswari
    Raman, Balambal
    Wares, Fraser
    Ramachandran, Ranjani
    Thomas, Aleyamma
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2011, 133 (05) : 529 - 534
  • [35] Occurrence and predictors of adverse events associated with Linezolid in the treatment of patients with MDR-TB
    Oehadian, A.
    Bastos, M. L.
    Centis, R.
    D'Ambrosio, L.
    Migliorie, G. B.
    Santoso, P.
    Ruslami, R.
    Menzies, D.
    [J]. PULMONOLOGY, 2024, 30 (02): : 184 - 187
  • [36] Treatment Results of Multidrug Resistant Tuberculosis (MDR-TB) Patients in the Aegean Region
    Karaman, Onur
    Varol, Yelda
    Bicmen, Can
    Akarca, Tulay
    Dereli, Sevket
    Ozbakir, Didem
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [37] Treatment outcomes of patients with MDR-TB and its determinants at referral hospitals in Ethiopia
    Wakjira, Mengistu K.
    Sandy, Peter T.
    Mavhandu-Mudzusi, A. H.
    [J]. PLOS ONE, 2022, 17 (02):
  • [38] Linezolid-induced peripheral neuropathy in patients receiving MDR-TB treatment
    Skyllberg, Erik
    Young, Rebekah
    Sharma, Akhilesh
    Chen, Christabelle
    Tiberi, Simon
    White, Veronica
    Kunst, Heinke
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [39] Nurses as providers of emotional support to patients with MDR-TB
    Chalco, K.
    Wu, D. Y.
    Mestanza, L.
    Munoz, M.
    Llaro, K.
    Guerra, D.
    Palacios, E.
    Furin, J.
    Shin, S.
    Sapag, R.
    [J]. INTERNATIONAL NURSING REVIEW, 2006, 53 (04) : 253 - 260
  • [40] Prevalence of hypothyroidism among MDR-TB patients in Botswana
    Modongo, Chawangwa
    Zetola, Nicola M.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (11) : 1561 - 1562
12345